Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Gaine (Dublin, Ireland). Current medical treatment of pulmonary arterial hypertension. ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease

Member's Comments

No comment yet.

Related content which might interest you: The future of treatment for pulmonary arterial hypertension Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 The future of treatment for pulmonary arterial hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 The future of treatment for pulmonary arterial hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 The future of treatment for pulmonary arterial hypertension Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Real-life data on the medical therapy of pulmonary arterial and chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – PAH and CTEPH Year: 2017 Identification of treatment goals in paediatric pulmonary arterial hypertension Source: Eur Respir J 2014; 44: 1616-1626 Year: 2014 Optimising the management of pulmonary arterial hypertension patients: emergency treatments Source: Eur Respir Rev 2010 19: 204-211 Year: 2010 Early detection and management of pulmonary arterial hypertension Source: Eur Respir Rev 2012 21: 306-312 Year: 2012 Treatment options for paediatric pulmonary arterial hypertension Source: Eur Respir Rev 2010 19: 321-330 Year: 2010 The challenges in paediatric pulmonary arterial hypertension Source: Eur Respir Rev 2014; 23: 498-504 Year: 2014 General and standard therapy of pulmonary arterial hypertension Source: International Congress 2017 – Russian Programme 2017 Year: 2017 Risk stratification and medical therapy of pulmonary arterial hypertension Source: Eur Respir J, 53 (1) 1801889; 10.1183/13993003.01889-2018 Year: 2019 Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children Source: Eur Respir J 2011; 37: 70-77 Year: 2011 Pulmonary arterial hypertension: treatment options Source: International Congress 2018 – ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED Year: 2018 Modern age pathology of pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Update on current treatment options of pulmonary hypertension Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine Year: 2006 Pulmonary arterial hypertension: tailoring treatment to risk in the current era Source: Eur Respir Rev, 26 (146) 170095; 10.1183/16000617.0095-2017 Year: 2017 Trends in pulmonary arterial hypertension Source: Eur Respir Rev 2009; 18: 7-12 Year: 2009